Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: CytoTools's Subsidiary CytoPharma Applies For Patent In Field Of Oncology

June 14 (Reuters) - CYTOTOOLS AG  T5OG.DE :
    * CYTOPHARMA, SUBSIDIARY OF CYTOTOOLS, PROTECTS NEW DRUG
CANDIDATES BY APPLYING FOR A PATENT FOR USE IN ONCOLOGY
    * NEW DRUG CANDIDATES OPEN UP THE POSSIBILITY OF INNOVATIVE
CANCER
THERAPY

Source text for Eikon:  ID:nEQ8R4J0Va 
Further company coverage:  T5OG.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on bioXXmed AG

See all news